Literature DB >> 20193836

Higher incidence of mild cognitive impairment in familial hypercholesterolemia.

Daniel Zambón1, Melibea Quintana, Pedro Mata, Rodrigo Alonso, Jaume Benavent, Felix Cruz-Sánchez, Jordi Gich, Miguel Pocoví, Fernando Civeira, Sebastian Capurro, David Bachman, Kumar Sambamurti, Joyce Nicholas, Miguel A Pappolla.   

Abstract

OBJECTIVE: Hypercholesterolemia is an early risk factor for Alzheimer's disease. Low-density lipoprotein (LDL) receptors might be involved in this disorder. Our objective was to determine the risk of mild cognitive impairment in a population of patients with heterozygous familial hypercholesterolemia, a condition involving LDL receptor dysfunction and lifelong hypercholesterolemia.
METHODS: By using a cohort study design, patients with familial hypercholesterolemia (N=47) meeting inclusion criteria and comparison patients without familial hypercholesterolemia (N=70) were consecutively selected from academic specialty and primary care clinics, respectively. All patients were older than 50 years. Those with disorders that could affect cognition, including history of stroke or transient ischemic attacks, were excluded from both groups. Thirteen standardized neuropsychologic tests were performed in all subjects. Mutational analysis was performed in patients with familial hypercholesterolemia, and brain imaging was obtained in those with familial hypercholesterolemia and mild cognitive impairment.
RESULTS: Patients with familial hypercholesterolemia showed a high incidence of mild cognitive impairment compared with those without familial hypercholesterolemia (21.3% vs 2.9%; P=.00). This diagnosis was unrelated to structural pathology or white matter disease. There were significant differences, independent of apolipoprotein E4 or E2 status, between those with familial hypercholesterolemia and those with no familial hypercholesterolemia in several cognitive measures, all in the direction of worse performance for those with familial hypercholesterolemia.
CONCLUSION: Because prior studies have shown that older patients with sporadic hypercholesterolemia do not show a higher incidence of mild cognitive impairment, the findings presented suggest that early exposure to elevated cholesterol or LDL receptor dysfunction may be risk factors for mild cognitive impairment. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20193836      PMCID: PMC2844655          DOI: 10.1016/j.amjmed.2009.08.015

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  33 in total

Review 1.  Link between heart disease, cholesterol, and Alzheimer's disease: a review.

Authors:  D L Sparks; T A Martin; D R Gross; J C Hunsaker
Journal:  Microsc Res Tech       Date:  2000-08-15       Impact factor: 2.769

2.  A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease.

Authors:  L M Refolo; M A Pappolla; J LaFrancois; B Malester; S D Schmidt; T Thomas-Bryant; G S Tint; R Wang; M Mercken; S S Petanceska; K E Duff
Journal:  Neurobiol Dis       Date:  2001-10       Impact factor: 5.996

3.  Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model.

Authors:  L M Refolo; B Malester; J LaFrancois; T Bryant-Thomas; R Wang; G S Tint; K Sambamurti; K Duff; M A Pappolla
Journal:  Neurobiol Dis       Date:  2000-08       Impact factor: 5.996

4.  The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort.

Authors:  M F Elias; A Beiser; P A Wolf; R Au; R F White; R B D'Agostino
Journal:  Arch Neurol       Date:  2000-06

5.  Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study.

Authors:  S Kalmijn; D Foley; L White; C M Burchfiel; J D Curb; H Petrovitch; G W Ross; R J Havlik; L J Launer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-10       Impact factor: 8.311

6.  Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease.

Authors:  Miia Kivipelto; Eeva-Liisa Helkala; Mikko P Laakso; Tuomo Hänninen; Merja Hallikainen; Kari Alhainen; Susan Iivonen; Arto Mannermaa; Jaakko Tuomilehto; Aulikki Nissinen; Hilkka Soininen
Journal:  Ann Intern Med       Date:  2002-08-06       Impact factor: 25.391

Review 7.  Cholesterol, oxidative stress, and Alzheimer's disease: expanding the horizons of pathogenesis.

Authors:  Miguel A Pappolla; Mark A Smith; Tara Bryant-Thomas; Nicolas Bazan; Suzana Petanceska; George Perry; Leon J Thal; Mary Sano; Lorenzo M Refolo
Journal:  Free Radic Biol Med       Date:  2002-07-15       Impact factor: 7.376

8.  Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology.

Authors:  M A Pappolla; T K Bryant-Thomas; D Herbert; J Pacheco; M Fabra Garcia; M Manjon; X Girones; T L Henry; E Matsubara; D Zambon; B Wolozin; M Sano; F F Cruz-Sanchez; L J Thal; S S Petanceska; L M Refolo
Journal:  Neurology       Date:  2003-07-22       Impact factor: 9.910

Review 9.  Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia.

Authors:  Fernando Civeira
Journal:  Atherosclerosis       Date:  2004-03       Impact factor: 5.162

10.  Statins, incident Alzheimer disease, change in cognitive function, and neuropathology.

Authors:  Z Arvanitakis; J A Schneider; R S Wilson; J L Bienias; J F Kelly; D A Evans; D A Bennett
Journal:  Neurology       Date:  2008-01-16       Impact factor: 9.910

View more
  35 in total

Review 1.  Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies.

Authors:  Nina E Shepardson; Ganesh M Shankar; Dennis J Selkoe
Journal:  Arch Neurol       Date:  2011-10

2.  Dietary cholesterol degrades rabbit long term memory for discrimination learning but facilitates acquisition of discrimination reversal.

Authors:  Bernard G Schreurs; Carrie A Smith-Bell; Desheng Wang; Lauren B Burhans
Journal:  Neurobiol Learn Mem       Date:  2013-09-25       Impact factor: 2.877

Review 3.  Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics.

Authors:  Yajun Duan; Ke Gong; Suowen Xu; Feng Zhang; Xianshe Meng; Jihong Han
Journal:  Signal Transduct Target Ther       Date:  2022-08-02

Review 4.  Cholesterol in the retina: the best is yet to come.

Authors:  Irina A Pikuleva; Christine A Curcio
Journal:  Prog Retin Eye Res       Date:  2014-04-04       Impact factor: 21.198

Review 5.  Cholesterol in brain disease: sometimes determinant and frequently implicated.

Authors:  Mauricio G Martín; Frank Pfrieger; Carlos G Dotti
Journal:  EMBO Rep       Date:  2014-09-15       Impact factor: 8.807

6.  ApoB100/LDLR-/- hypercholesterolaemic mice as a model for mild cognitive impairment and neuronal damage.

Authors:  Carlos Ramírez; Saleta Sierra; Inmaculada Tercero; Jose Antonio Vázquez; Antonia Pineda; Tatiana Manrique; Javier S Burgos
Journal:  PLoS One       Date:  2011-07-26       Impact factor: 3.240

7.  Cerebral accumulation of dietary derivable plant sterols does not interfere with memory and anxiety related behavior in Abcg5-/- mice.

Authors:  Tim Vanmierlo; Kris Rutten; Leonie C van Vark-van der Zee; Silvia Friedrichs; Vincent W Bloks; Arjan Blokland; Frans C Ramaekers; Eric Sijbrands; Harry Steinbusch; Jos Prickaerts; Folkert Kuipers; Dieter Lütjohann; Monique Mulder
Journal:  Plant Foods Hum Nutr       Date:  2011-06       Impact factor: 3.921

8.  Cholesterol: its regulation and role in central nervous system disorders.

Authors:  Matthias Orth; Stefano Bellosta
Journal:  Cholesterol       Date:  2012-10-17

9.  Links between copper and cholesterol in Alzheimer's disease.

Authors:  Ya Hui Hung; Ashley I Bush; Sharon La Fontaine
Journal:  Front Physiol       Date:  2013-05-16       Impact factor: 4.566

10.  Dietary Cholesterol Concentration and Duration Degrade Long-Term Memory of Classical Conditioning of the Rabbit's Nictitating Membrane Response.

Authors:  Bernard G Schreurs; Desheng Wang; Carrie A Smith-Bell; Lauren B Burhans; Roger Bell; Jimena Gonzalez-Joekes
Journal:  Int J Alzheimers Dis       Date:  2012-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.